Literature DB >> 17010367

Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokines.

Patrizia Giannetti1, Andrea Facciabene, Nicola La Monica, Luigi Aurisicchio.   

Abstract

Among the experimental animal models, mice remain the most widely used for the evaluation of immunotherapeutic strategies. Vaccines against parasites and viral antigens are commonly administered to the appropriate mouse strain which also allows testing of the therapeutic effect. Similarly, in mice transgenic for human tumor associated antigens (TAA), cancer vaccines must lead to breakage of immune tolerance to elicit a significant effect on the tumor. However, one of the major drawbacks in the monitoring of cellular immune responses induced by vaccination is that functional immunological assays require suppression of the animals to collect the spleen or lymph nodes for analysis. Here, we report the application of a rapid intracellular staining (ICS) method to quantify antigen-specific T cells responses in small volumes of murine blood. Genetic vaccination with plasmid DNA followed by electroporation (DNA-EP) and the use of adenoviral vectors (Ad) encoding CEA as a model target antigen were applied to different strains of mice. Optimal blood volume, number of lymphocytes, sensitivity and reproducibility of intracellular staining for IFN-gamma were determined both in non-tolerant/wild type mice as well as in tolerant CEA transgenic mice upon restimulation of PBMCs with CEA peptides. Groups of vaccinated mice were then sacrificed and PBMCs and splenocytes from individual animals were compared for intracytoplasmic detection of IFN-gamma and TNF-alpha. A significant correlation was observed between splenic and blood immune responses. Finally, the cellular immune response was followed over time in groups of vaccinated mice. The kinetics of IFN-gamma producing effectors were measured after priming and successive boosting with adenoviral vectors. We show that intracellular staining for mouse PBMCs is a rapid and simple method to measure antigen-specific immune responses. It does not require animal euthanasia and mirrors the response observed in lymphoid organs such as the spleen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010367     DOI: 10.1016/j.jim.2006.08.004

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Authors:  Katharina Richard; Barbara J Mann; Aiping Qin; Eileen M Barry; Robert K Ernst; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

2.  Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen.

Authors:  Luigi Aurisicchio; Giuseppe Roscilli; Emanuele Marra; Laura Luberto; Rita Mancini; Nicola La Monica; Gennaro Ciliberto
Journal:  Hum Gene Ther       Date:  2015-06       Impact factor: 5.695

3.  Linear DNA amplicons as a novel cancer vaccine strategy.

Authors:  Antonella Conforti; Erika Salvatori; Lucia Lione; Mirco Compagnone; Eleonora Pinto; Clay Shorrock; James A Hayward; Yuhua Sun; Ben Minghwa Liang; Fabio Palombo; Brian Viscount; Luigi Aurisicchio
Journal:  J Exp Clin Cancer Res       Date:  2022-06-06

4.  Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.

Authors:  Luigi Aurisicchio; Daniela Peruzzi; Gloria Koo; Wei-Zen Wei; Nicola La Monica; Gennaro Ciliberto
Journal:  Hum Gene Ther       Date:  2013-12-21       Impact factor: 5.695

5.  A novel minigene scaffold for therapeutic cancer vaccines.

Authors:  Luigi Aurisicchio; Arthur Fridman; Ansuman Bagchi; Elisa Scarselli; Nicola La Monica; Gennaro Ciliberto
Journal:  Oncoimmunology       Date:  2014-01-16       Impact factor: 8.110

6.  Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery.

Authors:  Yanpu He; Celestine Hong; Emily Z Yan; Samantha J Fletcher; Ge Zhu; Mengdi Yang; Yingzhong Li; Xin Sun; Darrell J Irvine; Jiahe Li; Paula T Hammond
Journal:  Sci Adv       Date:  2020-06-12       Impact factor: 14.136

7.  COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.

Authors:  Antonella Conforti; Emanuele Marra; Fabio Palombo; Giuseppe Roscilli; Micol Ravà; Valeria Fumagalli; Alessia Muzi; Mariano Maffei; Laura Luberto; Lucia Lione; Erika Salvatori; Mirco Compagnone; Eleonora Pinto; Emiliano Pavoni; Federica Bucci; Grazia Vitagliano; Daniela Stoppoloni; Maria Lucrezia Pacello; Manuela Cappelletti; Fabiana Fosca Ferrara; Emanuela D'Acunto; Valerio Chiarini; Roberto Arriga; Abraham Nyska; Pietro Di Lucia; Davide Marotta; Elisa Bono; Leonardo Giustini; Eleonora Sala; Chiara Perucchini; Jemma Paterson; Kathryn Ann Ryan; Amy-Rose Challis; Giulia Matusali; Francesca Colavita; Gianfranco Caselli; Elena Criscuolo; Nicola Clementi; Nicasio Mancini; Rüdiger Groß; Alina Seidel; Lukas Wettstein; Jan Münch; Lorena Donnici; Matteo Conti; Raffaele De Francesco; Mirela Kuka; Gennaro Ciliberto; Concetta Castilletti; Maria Rosaria Capobianchi; Giuseppe Ippolito; Luca G Guidotti; Lucio Rovati; Matteo Iannacone; Luigi Aurisicchio
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 11.454

8.  An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform.

Authors:  Arthur Fridman; Adam C Finnefrock; Daniela Peruzzi; Irene Pak; Nicola La Monica; Ansuman Bagchi; Danilo R Casimiro; Gennaro Ciliberto; Luigi Aurisicchio
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

9.  A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines.

Authors:  Daniela Peruzzi; Sridhar Dharmapuri; Agostino Cirillo; Bruno Ercole Bruni; Alfredo Nicosia; Riccardo Cortese; Stefano Colloca; Gennaro Ciliberto; Nicola La Monica; Luigi Aurisicchio
Journal:  Vaccine       Date:  2009-01-20       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.